Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei
Open Access
- 30 November 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (11) , e0208277
Abstract
Mouse models have been essential to generate supporting data for the research of infectious diseases. Burkholderia pseudomallei, the etiological agent of melioidosis, has been studied using mouse models to investigate pathogenesis and efficacy of novel medical countermeasures to include both vaccines and therapeutics. Previous characterization of mouse models of melioidosis have demonstrated that BALB/c mice present with an acute infection, whereas C57BL/6 mice have shown a tendency to be more resistant to infection and may model chronic disease. In this study, either BALB/c or C57BL/6 mice were exposed to aerosolized human clinical isolates of B. pseudomallei. The bacterial strains included HBPUB10134a (virulent isolate from Thailand), MSHR5855 (virulent isolate from Australia), and 1106a (relatively attenuated isolate from Thailand). The LD50 values were calculated and serial sample collections were performed in order to examine the bacterial burdens in tissues, histopathological features of disease, and the immune response mounted by the mice after exposure to aerosolized B. pseudomallei. These data will be important when utilizing these models for testing novel medical countermeasures. Additionally, by comparing highly virulent strains with attenuated isolates, we hope to better understand the complex disease pathogenesis associated with this bacterium.Keywords
Funding Information
- Defense Threat Reduction Agency
This publication has 85 references indexed in Scilit:
- Development of a Murine Model for Aerosolized Ebolavirus Infection Using a Panel of Recombinant Inbred MiceViruses, 2012
- Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lungMucosal Immunology, 2012
- Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expressionProceedings of the National Academy of Sciences, 2011
- Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated InflammationImmunity, 2011
- Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteriaNature Immunology, 2010
- Complement: a key system for immune surveillance and homeostasisNature Immunology, 2010
- Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasomeProceedings of the National Academy of Sciences of the United States of America, 2010
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+regulatory T cellsProceedings of the National Academy of Sciences, 2008
- Environmental Factors That Affect the Survival and Persistence ofBurkholderia pseudomalleiApplied and Environmental Microbiology, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006